STEAP3 and colorectal cancer: Additionally, lncRNA STEAP3‐AS1 has been implicated in promoting colorectal cancer progression through the STEAP3‐AS1/STEAP3/Wnt/β‐catenin axis, suggesting the potential utility of these lncRNAs as diagnostic biomarkers or therapeutic targets for improving colorectal cancer treatment.33